Duodenal Mucosal Resurfacing: A Breakthrough in Weight Loss and Metabolic Health with GLP-1 Medications
Duodenal mucosal resurfacing (DMR), an investigational endoscopic procedure, has shown promise in helping patients maintain weight loss after discontinuing GLP-1 receptor agonist medications such as Ozempic and Wegovy, according to findings presented at Digestive Disease Week® (DDW) 2026. The minimally invasive technique, which uses hydrothermal ablation to renew the lining of the upper small intestine, … Read more